Drug · DIN 02382059
ALLERJECT
SINGLE-USE PREFILLED AUTO-INJECTOR
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 14, 2025; first marketed December 11, 2012.
- Drug Identification Number (DIN)
- 02382059
- Company (DIN owner)
- Valeo Pharma Inc.Oakville, Ontario, Canada
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Epinephrine C01CA24
- Class
- Human
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EPINEPHRINE | 0.15 MG | 0.15 ML |
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “allerject”. A notice may cover another product or only some lots: read it to see what it covers.
- Allerject 0.15 mg / 0.15 mL (2015-10-28)October 28, 2015 · Drugs · Product safety · Type I
- Allerject 0.3 mg / 0.3 mL (2015-10-28)October 28, 2015 · Drugs · Product safety · Type I
- Allerject (2015-06-13)June 16, 2015 · Drugs · Product safety · Type I
- Two Lots of Allerject (0.15 mg / 0.15mL auto-injector) For Use In Children Recalled Due to Manufacturing DefectJune 13, 2015 · Drugs
Other DINs named ALLERJECT
- DIN 02382067 · Cancelled Post Market